Possibilities and Measures to Improve Health Literacy

March 14, 2023 updated by: Medical University of Graz

Health literacy describes one's capability to understand and implement health information in daily practice. Hospital referral letters remain a main information tool for patients as well as physicians with information about therapeutic measures done during hospital stay as well as recommendations on drug intake, further therapies or diagnostics to be done after hospital discharge.

With increasing medical knowledge, hospital referral letters have become more difficult to understand for patients and stakeholders alike. The aim of this study is to develop a patient-friendly referral letter that is easier to understand while transporting the same amount of information for patients as well as stakeholders.

Study Overview

Detailed Description

During the last decades healthcare systems had to face new challenges in patient care: Along with increasing life expectancy and better treatment options for many diseases also the amount of chronically ill elderly patients increased. Much is expected of this particular patient group regarding self-management and comprehension of their medical condition. However, also younger patients or parents can be overstrained with self-care demands. Recent research among the US population showed that poor health literacy is associated with more frequent healthcare utilization and expenditures, showing that poor health literacy also has impact on the healthcare system itself.

In this respect, adequate patient information is crucial. With every hospital visit - after hospitalisation or in the outpatient clinic - patients usually receive a referral letter which ideally describes the present symptoms or illness, the treatment carried out and steps the patient should take by herself/himself in the near or distant future. In reality these notes are often written in medical language that is difficult or impossible to understand for lays and usually contain information that is intended rather for communication between physicians or therapists. However, it is difficult to find a middle course that provides patients with adequate information while at the same time not losing informational content of immediate relevance for all professions involved in patient care.

Despite great efforts of all departments of the University Hospital Graz and all Styrian (KAGES) hospitals, adequate referral letters that also suffice the demands of stakeholders such as general practitioners, remains an issue needing further attention. Up to now, there has been no referral letter that provides both medical information for professionals as well as information that addresses the patient directly and is adapted to the respective medical knowledge.

Aim and Hypothesis The aim of this study is to develop and test an improved referral letter within the KAGES-wide project "Entlassungsdokumentation NEU"

Study Type

Observational

Enrollment (Actual)

982

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Styria
      • Graz, Styria, Austria, 8036
        • Medical University Graz

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

1000

Description

Inclusion Criteria:

  • Patients of any department of the University Hospital Graz at the time of hospital discharge, or during waiting hours at the outpatient department (since those patients can be regarded as not critically ill and in a mental and physical state that will allow them to fill out a questionnaire).
  • Physicians of any department of the University Hospital Graz and outside of the hospital, irrespective of their specialisation
  • Nursing staff of any department of the University Hospital Graz and outside of the hospital, irrespective of the additional training
  • Students of the Medical University of Graz, irrespective of the field of study

Exclusion Criteria:

  • Patients who are critically ill and/or mentally or physically obviously not capable to partake in the survey
  • Participants who are unwilling to partake, i.e. did not fill out the informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Current referral letters
One letter will be chosen from the selection of current referral letters (of average quality according to the results of the study mentioned above). Any data that would allow identification of the respective patient (i.e. name, date of birth, social insurance number, address) will be anonymised (not blackened in order not to disturb fluent reading).
Participants are handed a questionnaire to asses comprehension of medical content provided in the referral letters.
New referral letters
The other one will be a corrected version of the first letter according to the ELGA (Elektronische Gesundheitsakte) requirements and the identified needs of patients and stakeholders (see Previous Work 1).
Participants are handed a questionnaire to asses comprehension of medical content provided in the referral letters.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The primary endpoint of the study is the comprehension of medical content.
Time Frame: 1 day (single measurement by means of questionnaire)
The comprehension of medical content is assessed with a questionnaire-based survey encompassing specific questions inquiring the understanding of medical information delivered in the referral letters. All questions are answered based on a Likert-scale. Improvement of comprehension will be measured via comparison of the results between the two groups.
1 day (single measurement by means of questionnaire)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective satisfaction with the referral letter
Time Frame: 1 day (single measurement by means of questionnaire)
Subjective satisfaction is assessed with a questionnaire-based survey encompassing specific questions inquiring the understanding of medical information delivered in the referral letters. All questions are answered based on a Likert-scale. Improvement of comprehension will be measured via comparison of the results between the two groups.
1 day (single measurement by means of questionnaire)
Influence of demographic parameters on the understanding of medical content
Time Frame: 1 day (single measurement by means of questionnaire)
The demographic parameters include age, gender, level of education and profession. The impact of demographic parameters will be measured by setting the survey results of both study groups into relation with age, gender, level of education or profession.
1 day (single measurement by means of questionnaire)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 15, 2019

Primary Completion (Actual)

December 31, 2021

Study Completion (Actual)

December 31, 2021

Study Registration Dates

First Submitted

November 4, 2020

First Submitted That Met QC Criteria

November 12, 2020

First Posted (Actual)

November 13, 2020

Study Record Updates

Last Update Posted (Actual)

March 15, 2023

Last Update Submitted That Met QC Criteria

March 14, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • EK_NR_31-366 ex 18/19

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Care Utilization

Clinical Trials on Survey based on questionnaire (self-designed)

Subscribe